Clindamycin phosphate 1% gel in acne vulgaris

Adv Ther. 2001 Nov-Dec;18(6):244-52. doi: 10.1007/BF02850194.

Abstract

A 12-week study compared Clindagel, a unique water-based gel formulation of clindamycin phosphate 1%, administered once daily, and Cleocin T, a slightly different gel formulation indicated for twice-daily use, in the treatment of acne vulgaris. Clindagel was safe and effective and equivalent to Cleocin T gel, albeit with a better tolerability profile. Clindagel is a viable alternative to Cleocin T gel.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Adolescent
  • Adult
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Anti-Infective Agents, Local / adverse effects
  • Anti-Infective Agents, Local / therapeutic use*
  • Child
  • Clindamycin / adverse effects
  • Clindamycin / analogs & derivatives*
  • Clindamycin / therapeutic use*
  • Consumer Product Safety
  • Double-Blind Method
  • Female
  • Gels
  • Humans
  • Male
  • Middle Aged

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Gels
  • Clindamycin
  • clindamycin phosphate